1The National Institute Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333:1 581-1 587.
2Clark WM,Wissman S,Albers GW,et al.Recombinant tissue-type plasminogen activator (Alteplase) for ischernic stroke 3-5 hours after symptom onset:The ATLANTIS study:a randomized controlled trial.Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke[J].JAMA,1999,282:2 019-2 026.
3Hacke W,Kaste M,Fieschi C,et al.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke.The European Cooperative Acute Stroke Study (ECASS)[J].JAMA,1995,274:1 017-1 025.
4Hacke W,Kaste M,Fieschi C,et al.Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous Alteplase in acute ischaemic stroke (ECASS Ⅱ).Second European-Australasian Acute Stroke Study Investigators[J].Lancet,1998,352:1 245-1 251.
5Albers GW,Amarenco P,Easton JD.Antithrombotic and thrombolytic therapy for ischemic stroke:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126(Sup):483-512.
6Bourekas EC,Slivka AP,Shah R.Intraarterial thrombolytic therapy within 3 hours of the onset of stroke[J].Neurosurgery,2004,54(1):39-44.
7Patel S,Levine S,Tilley BC,et al.Lack of clinical significance of early ischemic changes on computerd tomography in acute stroke[J].JAMA,2001,286:2830-2838.
8Derex L,Nighoghossian N,Hermier M,et al.Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI[J].Cerebrovasc Dis,2004,17(2/3):238-241.
9Derex L,Hermier M,Adeleine P,Pialat JB.Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator[J].J Neurol Neurosurg Psychiatry,2005,76 (1):70-75.
10Wang X,Tsuji K,Lee SR.Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke[J].Stroke,2004,35 (Sup):2 726-2 730.
